_1920x880_9d2.jpg)
Molecular genetic diagnostics of primary immunodeficiencies (PID) is a diagnostic approach aimed at identifying genetic mutations that cause dysfunctions of the immune system. Primary immunodeficiencies are a group of inherited disorders in which the immune system is unable to adequately protect the body from infections. Molecular genetic testing makes it possible to accurately determine the specific type of PID, confirm the hereditary nature of the disease, and select the most appropriate treatment strategy.
Why is molecular genetic diagnostics important?
- Accurate diagnosis. PID represents a complex group of disorders comprising more than 400 genetically defined conditions. Molecular genetic diagnostics enables precise identification of the specific genetic defect, which is critical for correct diagnosis and management.
- Determination of inheritance pattern. Genetic testing allows clarification of the mode of inheritance (for example, autosomal recessive or X-linked), making it possible to assess risks for other family members.
- Selection of treatment strategy. Identification of the causative mutation can directly influence treatment decisions. For certain forms of PID, hematopoietic stem cell transplantation may be required, whereas others can be managed with immunotherapy or replacement therapy.
Which primary immunodeficiencies can be detected using molecular genetic diagnostics?
- Severe combined immunodeficiency (SCID). Severe conditions characterized by the absence or dysfunction of T and B lymphocytes.
- X-linked agammaglobulinemia. A disorder of antibody production due to the absence of mature B cells.
- DiGeorge syndrome. A genetic condition associated with absence or underdevelopment of the thymus, leading to T-cell deficiency.
- Chronic granulomatous disease (CGD). An inherited disorder in which phagocytes (neutrophils and macrophages) are unable to effectively kill bacteria and fungi.
- Wiskott–Aldrich syndrome. An inherited condition caused by mutations in the WAS gene, affecting immune function and platelet activity.
- Complement deficiencies. Disorders of the complement system that result in increased susceptibility to infections.
Indications for molecular genetic diagnostics of PID
- Suspected PID. Frequent, severe, or atypical infections that respond poorly to standard treatment.
- Family history. A history of PID or early deaths from infections within the family warrants genetic evaluation to assess risks.
- Abnormal immunological test results. Reduced immunoglobulin levels, deficiencies of specific immune cell populations, or other abnormalities in blood tests.
- Ineffectiveness of standard therapy. Lack of response to conventional treatment of infections, particularly in children, necessitates further diagnostic clarification.
Advantages of molecular genetic diagnostics
- Early diagnosis. Enables initiation of therapy at early stages of disease, improving prognosis and quality of life.
- Personalized treatment. Therapy can be tailored according to the specific type and severity of PID. Some patients may require regular immunoglobulin replacement, while others may need bone marrow transplantation.
- Genetic counseling. Families receive information on recurrence risks for future children and guidance on family planning.
Molecular genetic diagnostics of primary immunodeficiencies (PID) plays a crucial role in the identification and management of these complex disorders. Modern diagnostic technologies allow precise determination of the genetic cause of disease, opening opportunities for personalized therapy and improved patient outcomes. Early diagnosis combined with consultation by experienced specialists helps optimize disease management and minimize risks for both patients and their families.
Why undergo PID diagnostics in Belarus?
Belarusian medical laboratories utilize advanced molecular genetic technologies that ensure high accuracy and reliability of results. Experienced geneticists and immunologists provide comprehensive interpretation of data and develop individualized treatment strategies.
Q&A
Молекулярно-генетическая диагностика — это очень точный метод, но есть редкие случаи, когда мутация не выявляется или результат требует дополнительного подтверждения.
Да, в случаях высокого риска молекулярно-генетическая диагностика может быть проведена даже новорождённым, особенно если есть семейная история ПИД.
Врач-иммунолог и генетический консультант помогут разработать план лечения и дать рекомендации по дальнейшему наблюдению. Также может потребоваться тестирование других членов семьи.
